Hematopoietic Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem CellsTransplantation, HomologousStem Cell TransplantationTransplantation ConditioningGraft vs Host DiseaseBone Marrow TransplantationHematologic NeoplasmsStem CellsPeripheral Blood Stem Cell TransplantationTransplantation ChimeraMyeloablative AgonistsWhole-Body IrradiationHematopoietic Stem Cell MobilizationGraft SurvivalTreatment OutcomeTissue DonorsLiver TransplantationAntigens, CD34HematopoiesisBusulfanMultiple MyelomaCord Blood Stem Cell TransplantationHistocompatibility TestingHistocompatibilityRecurrenceCombined Modality TherapyRetrospective StudiesMelphalanImmunosuppressive AgentsVidarabineGraft vs Tumor EffectRemission InductionChimerismLeukemiaCell TransplantationKidney TransplantationBone Marrow CellsGraft vs Leukemia EffectCyclophosphamideCell DifferentiationTransplantation ImmunologySalvage TherapyDisease-Free SurvivalSurvival AnalysisTime FactorsSurvival RateGranulocyte Colony-Stimulating FactorLymphoma, Non-HodgkinMesenchymal Stem Cell TransplantationBone MarrowFlow CytometryCell LineageHLA AntigensColony-Forming Units AssayAntineoplastic Combined Chemotherapy ProtocolsLymphocyte TransfusionLeukemia, Myeloid, AcuteMice, Inbred C57BLMyelodysplastic SyndromesStem Cell NicheGraft RejectionHematologic DiseasesSiblingsAdult Stem CellsHeart TransplantationFollow-Up StudiesCells, CulturedHepatic Veno-Occlusive DiseaseTransplantation, IsogeneicCell SeparationFetal BloodT-LymphocytesLung TransplantationUnrelated DonorsOrgan TransplantationLeukapheresisAntilymphocyte SerumSevere Combined ImmunodeficiencyLymphocyte DepletionBone Marrow PurgingImmunosuppressionEmbryonic Stem CellsHodgkin DiseaseCytarabineTransplantationCarmustineEtoposidePrecursor Cell Lymphoblastic Leukemia-LymphomaBlood Transfusion, AutologousAcute DiseaseCytomegalovirus InfectionsPrognosisAnemia, AplasticCell ProliferationLeukemia, Myelogenous, Chronic, BCR-ABL PositiveMesenchymal Stromal CellsDonor SelectionMultipotent Stem Cells